Posts Tagged 'hip replacement recall'

Jury hears closing arguments in DePuy hip implant case

According to the Los Angeles Times, healthcare giant Johnson & Johnson played “Russian roulette” with patient safety by ignoring high failure rates and surgeons’ complaints about its once-popular artificial hip, a Los Angeles jury was told during closing arguments at a high-stakes medical trial for the company.

Read more about the DePuy hip replacement trial…

 

FDA wants hip manufacturers to prove devices are safe before continuing to sell them

The U.S. Food and Drug Administration (FDA) has issued a proposal that would require metal-on-metal hip manufacturers to prove their current devices are safe before continuing to sell them. As many as 500,000 Americans were estimated to have received an all-metal hip implant since they first appeared on the market.

Read more about complications linked to metal hip replacements…

Smith & Nephew recalls hip replacement component due to side effects concerns

In June 2012, Smith & Nephew issued a worldwide recall of the metal cup component of its R3 Acetabular System hip replacements. In a press release announcing the recall, Smith & Nephew stated that patients who received an R3 hip implant had reported higher rate of problems with the device than with other hip replacements.

Read more about the Smith & Nephew hip replacement recall…

Smith & Nephew recalls metal-on-metal hip replacement component

British medical device company Smith & Nephew has recalled the cup component of its R3 Acetabular System, a type of metal-on-metal hip replacement. The recall comes after the company received a higher than normal number of complaints from patients who received the device.

Read more about the Smith & Nephew recall…

Smith & Nephew pulls metal-on-metal hip component

Smith & Nephew is withdrawing the optional metal liner, or cup, component of its R3 Acetabular System all-metal artificial hip systems, following a higher than normal level of patient problems with the device. The decision follows an analysis of clinical results showing that 1.6 percent of patients with the system needed revision surgery each year.

Read more about the Smith and Nephew hip replacement recall…

J&J began phasing out DePuy implants after FDA letter

The manufacturer of the recalled DePuy hip replacements began phasing out the implants after a Food and Drug Administration letter requested more safety studies on the device, according to internal company documents. Johnson & Johnson had previously insisted its 2010 recall of the DePuy ASR hip replacement was strictly a business decision and was not instigated by any FDA actions.

Click here to read more…

DePuy failure rate may be as high as 49%, doctors say

Two British orthopedics groups have warned that the failure rate of a hip replacement manufactured by DePuy could be as high as 49%, four times the rate that was reported at the time of the DePuy recall. According to data, uncovered by the British Orthopaedic Association and the British Hip Society, DePuy’s ASR XL Acetabular System failed in 21% of patients after four years and in 49% of patients after six. At least 600 DePuy lawsuits have been filed in the U.S. against the company so far.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.